At the End of the Clinical Trial: Does Access to Investigational Technology End as Well?

At the End of the Clinical Trial: Does Access to Investigational Technology End as Well?

Report

At the End of the Clinical Trial: Does Access to Investigational Technology End as Well?

This Article was solicited by invitation as part of a symposium on Health Care Technology: Regulation and Reimbursement. Medical research subjects increasingly are demanding (and litigating about) continued access to investigational technology after the clinical trial has concluded.

  • Use cases, geography and tags
  • Organizations that created, adopted or are mentioned
  • Ecosystem position
  • Link to the original asset
  • Comments and reactions